Virtu Financial’s Lexaria Bioscience LEXX Stock Holding History

Virtu Financial’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Buy	+1,260	New	+$13.7K	﹤0.01%	1429
2025 Q4	–	Sell	-1,957	Closed	-$28K	–	1971
2025 Q3	$28K	Buy	+1,957	New	+$28.4K	﹤0.01%	1235
2022 Q3	–	Sell	-732	Closed	-$33K	–	1990
2022 Q2	$33K	Sell	732 -70	-9%	-$2.81K	﹤0.01%	1230
2022 Q1	$40K	Buy	+802	New	+$45.4K	﹤0.01%	1184
2021 Q4	–	Sell	-796	Closed	-$75K	–	1965
2021 Q3	$75K	Buy	+796	New	+$76.3K	0.01%	1208

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Virtu Financial's LEXX Position: Q2 2026 in Review

Virtu Financial opened a new position in Lexaria Bioscience (LEXX) in Q2 2026: 1,260 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1429 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LEXX as recently as Q3 2025.

Virtu Financial first reported a position in LEXX in Q3 2021 and has held it in 5 quarters since. The position peaked at $75K in Q3 2021. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

Virtu Financial held 1,260 shares of Lexaria Bioscience worth $11K as of Q2 2026.
Lexaria Bioscience was a new Virtu Financial position in Q2 2026.
Lexaria Bioscience made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1429 holding.
Virtu Financial first reported a position in Lexaria Bioscience in Q3 2021 and has held it in 5 quarters since.
Virtu Financial's Lexaria Bioscience position peaked at $75K in Q3 2021.
29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.